Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Feb 23;3(3):290–300. doi: 10.1158/1940-6207.CAPR-09-0199

Figure 1.

Figure 1

Immunohistochemistry of IRS-1 and IRS-2 in normal proliferative phase endometrium and endometrial endometrioid carcinomas from three different patients. Tumor A, positive for both IRS-1 and IRS-2 (A and B). Tumor B, negative for IRS-1 and positive for IRS-2 (C and D). Tumor C, negative for both IRS-1 and IRS-2 (E and F). Normal endometrium (G and H), positive for both IRS-1 and IRS-2. Original magnification 200X.